Please Wait
Applying Filters...
menu
    • menu

    List of Inactive Ingredients used to produce Poloxamer 407 API listed on PharmaCompass with Finished Dosage Forms (Formulations)

    Client Email Product
    Renejix: CDMO with expertise in small molecule oral dosage, delivery tech, and multi-modality manufacturing.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Ribobay has expertise in oligonucleotides from siRNA, Antisense Oligonucleotides, miRNAs, and aptamers & Oligonucleotides CXOs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Poloxamer 407

    INACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    EXCIPIENTS BY APPLICATIONS

    MARKET PLACE

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 1CAPSULE

    02 1CAPSULE (IMMED./COMP. RELEASE)

    03 1CAPSULE, DELAYED ACTION

    04 1CAPSULE, ENTERIC COATED PELLETS

    05 1CAPSULE, EXTENDED RELEASE

    06 1EMULSION, CREAM

    07 2GEL

    08 1LOTION

    09 1POWDER, FOR ORAL SUSPENSION

    10 3SOLUTION

    11 2SUSPENSION

    12 1SUSPENSION, DROPS

    13 1TABLET

    14 1TABLET, FILM COATED

    filter clear-filterReset all filters

    PharmaCompass

    01

    Dosage Form : SUSPENSION

    POLOXAMER 407
    arrow
    AAPS 2024
    Not Confirmed

    Dosage Form : SUSPENSION

    USA
    arrow
    AAPS 2024
    Not Confirmed

    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Country
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    POLOXAMER 407

    Route : INTRATYMPANIC

    CAS : 691397134

    UNII : TUF2IVW3M2

    Potency Amount : 15.1

    Potency Unit : %W/W

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Dosage Form : SOLUTION

    POLOXAMER 407
    arrow
    AAPS 2024
    Not Confirmed

    Dosage Form : SOLUTION

    USA
    arrow
    AAPS 2024
    Not Confirmed

    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Country
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    POLOXAMER 407

    Route : OPHTHALMIC

    CAS : 691397134

    UNII : TUF2IVW3M2

    Potency Amount : 0.2

    Potency Unit : %

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Dosage Form : SUSPENSION, DROPS

    POLOXAMER 407
    arrow
    AAPS 2024
    Not Confirmed

    Dosage Form : SUSPENSION, DROPS

    USA
    arrow
    AAPS 2024
    Not Confirmed

    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Country
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    POLOXAMER 407

    Route : OPHTHALMIC

    CAS : 691397134

    UNII : TUF2IVW3M2

    Potency Amount : 0.1

    Potency Unit : %

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Dosage Form : CAPSULE

    POLOXAMER 407
    arrow
    AAPS 2024
    Not Confirmed

    Dosage Form : CAPSULE

    USA
    arrow
    AAPS 2024
    Not Confirmed

    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Country
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    POLOXAMER 407

    Route : ORAL

    CAS : 691397134

    UNII : TUF2IVW3M2

    Potency Amount : 0.9

    Potency Unit : MG

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Dosage Form : CAPSULE (IMMED./COMP. RELEASE)

    POLOXAMER 407
    arrow
    AAPS 2024
    Not Confirmed

    Dosage Form : CAPSULE (IMMED./COMP. RELEASE)

    USA
    arrow
    AAPS 2024
    Not Confirmed

    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Country
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    POLOXAMER 407

    Route : ORAL

    CAS : 691397134

    UNII : TUF2IVW3M2

    Potency Amount : 1

    Potency Unit : MG

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Dosage Form : CAPSULE, DELAYED ACTION

    POLOXAMER 407
    arrow
    AAPS 2024
    Not Confirmed

    Dosage Form : CAPSULE, DELAYED ACTION

    USA
    arrow
    AAPS 2024
    Not Confirmed

    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Country
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    POLOXAMER 407

    Route : ORAL

    CAS : 691397134

    UNII : TUF2IVW3M2

    Potency Amount : 40

    Potency Unit : MG

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    Dosage Form : CAPSULE, ENTERIC COATED PELLET...

    POLOXAMER 407
    arrow
    AAPS 2024
    Not Confirmed

    Dosage Form : CAPSULE, ENTERIC COATED PELLET...

    USA
    arrow
    AAPS 2024
    Not Confirmed

    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Country
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    POLOXAMER 407

    Route : ORAL

    CAS : 691397134

    UNII : TUF2IVW3M2

    Potency Amount : 5

    Potency Unit : MG

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    Dosage Form : CAPSULE, EXTENDED RELEASE

    POLOXAMER 407
    arrow
    AAPS 2024
    Not Confirmed

    Dosage Form : CAPSULE, EXTENDED RELEASE

    USA
    arrow
    AAPS 2024
    Not Confirmed

    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Country
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    POLOXAMER 407

    Route : ORAL

    CAS : 691397134

    UNII : TUF2IVW3M2

    Potency Amount : 5

    Potency Unit : MG

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    Dosage Form : POWDER, FOR ORAL SUSPENSION

    POLOXAMER 407
    arrow
    AAPS 2024
    Not Confirmed

    Dosage Form : POWDER, FOR ORAL SUSPENSION

    USA
    arrow
    AAPS 2024
    Not Confirmed

    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Country
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    POLOXAMER 407

    Route : ORAL

    CAS : 691397134

    UNII : TUF2IVW3M2

    Potency Amount : 126

    Potency Unit : MG/25.169GM

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    Dosage Form : SOLUTION

    POLOXAMER 407
    arrow
    AAPS 2024
    Not Confirmed

    Dosage Form : SOLUTION

    USA
    arrow
    AAPS 2024
    Not Confirmed

    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Country
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    POLOXAMER 407

    Route : ORAL

    CAS : 691397134

    UNII : TUF2IVW3M2

    Potency Amount : 50

    Potency Unit : MG/5ML

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF